Tradestie Institutional Equity Comparison Engine
CORT vs MTNB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CORT Overall Edge
CORT Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Corcept Therapeutics Inc. (CORT) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CORT trades at 13.0x Forward P/E with 11.5% operating margin (+64.0% YoY revenue) versus MTNB at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, CORT sits in CONSOLIDATION (19th %ile IV; Dealer Gamma Walls on Pro) against MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
CORT
CORT 13.0x vs MTNB N/M Fwd P/E
Growth & Margin Winner
CORT
Op Margin 11.5% vs 0.0% ยท YoY +64.0% vs -100.0%
Momentum & Technical Winner
CORT
1Y -13.5% vs -31.4% ยท 52W Pos 37% vs 22%
Options & Structure Winner
CORT
CONSOLIDATION (19th %ile IV) vs UNCLASSIFIED (N/A IV)
CORT
NASDAQ
Corcept Therapeutics Inc.
Pharmaceutical Preparations
$64.98
-4.15% 1D
Market Cap
$7.4B
1M Return
-44.12%
1Y Return
-13.49%
Forward P/E
13.0x
Unified AI Score
43.9 / 100
HOLD
Tech 25.0
Fund 56.0
Flow 69.0
Mom 55.0
MTNB
NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap
$979,904
1M Return
-46.7%
1Y Return
-31.35%
Forward P/E
N/M
Unified AI Score
54.6 / 100
HOLD
Tech 53.0
Fund 58.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CORT -13.49%
MTNB -31.35%
Spread: +17.86 pp (CORT Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CORT Revenue | MTNB Revenue | CORT Op. Margin | MTNB Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $250M | $0M | 35.6% | -12230.9% | CORT |
| FY2019 | $310M | $0M | 36.4% | -21067.4% | CORT |
| FY2020 | $350M | $0M | 36.2% | -15288.4% | CORT |
| FY2021 | $370M | $0M | 34.0% | -74954.5% | CORT |
| FY2022 | $400M | $0M | 28.0% | -771.3% | CORT |
| FY2023 | $480M | $0M | 22.2% | -2168.4% | CORT |
| FY2024 | $680M | N/A | 20.3% | N/A | CORT |
| FY2025 | $760M | N/A | 5.9% | N/A | CORT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CORT | MTNB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.4B | $979,904 | Larger Scale | CORT |
| Trailing P/E Ratio Valuation | 51.0x | N/M | Lower Multiple | CORT |
| Forward P/E Ratio Valuation | 13.0x | N/M | Lower Multiple | CORT |
| Revenue Growth (YoY) Growth | +64.0% | -100.0% | Higher Growth | CORT |
| Operating Margin (TTM) Profitability | 11.5% | 0.0% | Higher Margin | CORT |
| Net Profit Margin Profitability | 16.8% | 0.0% | Higher Margin | CORT |
| Return on Equity (ROE) Capital Efficiency | 22.1% | -147.5% | Higher ROE | CORT |
| 52-Week Range Position Momentum | 37% ($29โ$126) | 22% ($0โ$3) | Stronger Trend | CORT |
| Beta / 30D Volatility Risk Regime | 1.62ฮฒ ยท 81% Vol | -7.20ฮฒ ยท 147% Vol | Lower Realized Risk | CORT |
| Unified Institutional Score Composite Signal | 43.9 / 100 (HOLD) | 54.6 / 100 (HOLD) | Higher Composite | MTNB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CORT vs MTNB Buy Guide
CORT
CONSOLIDATION
112d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
19th %ile
IV Regime
Compressed (<25th %ile)
MTNB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CORT nor MTNB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.